HONG KONG -- Meihua International Medical Technologies is seeking to become the first Chinese company to undertake an initial public offering in the U.S. since regulators in both Beijing and Washington clamped down on such listings last month.
The Yangzhou-based medical device maker filed a preliminary prospectus with the U.S. Securities and Exchange Commission this week, aiming to raise as much as $69 million through an offering on the Nasdaq Stock Market.
